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Effects of etomidate on blood cortisol, insulin, and glucose
levels and PONV rates in smokers
Cevdet SÜMER1, Ömer Lütfi ERHAN2, Ayşe Belin ÖZER2, Fuat YILDIZ3

Aim: To observe differences in the effects of etomidate, used for anesthesia induction, on surgery-induced endocrine
response and postoperative nausea and vomiting (PONV) among nonsmokers and smokers.
Materials and methods: Eighty adult patients with ASA I-II risk status were randomly divided into 2 groups: smokers
(Group I, n = 40) and nonsmokers (Group II, n = 40). Patients were then further divided into subgroups according to the
drug used for anesthesia induction, either propofol (Group IP and Group IIP) or etomidate (Group IE and Group IIE).
Blood cortisol, insulin, glucose, and white blood cell (WBC) levels were measured and PONV scores were recorded.
Results: Blood cortisol values were significantly lower in Group IE and Group IIE compared to Group IP and Group IIP
during the 1st and 2nd hours after induction. By the 8th hour, blood insulin levels had increased significantly compared
to the baseline values in Groups IE, IP, and IIP. Blood glucose levels were significantly higher in Group IIE compared
to both Group IP and Group IIP. There was no significant difference between the WBC levels of the different groups.
PONV scores were significantly higher in Group IIE compared to the other groups.
Conclusion: We determined that the use of etomidate causes a lower stress response and more PONV compared to
propofol, while smoking increases the stress response and decreases PONV.
Key words: Anesthesia, smoking, cortisol, etomidate, PONV

Introduction
The health problems arising due to smoking and
the use of other tobacco products are well known.
Smoking affects not only the cardiovascular and
respiratory systems but also the endocrine system
(1,2). Smoking is known to affect the levels of
catecholamines, antidiuretic hormone (ADH),
growth hormone (GH), adrenocorticotropic
hormone (ACTH), prolactin, gonadotropins, and
insulin. Smoking may affect the hypothalamopituitary axis via central nervous system pathways;
thus, an increase in vasopressin and corticotrophinreleasing hormone (CRH) also increases the release

of ACTH. Impaired glucose tolerance is another
adverse effect of smoking (3-6).
Etomidate provides the best cardiovascular
stability but can cause nausea, vomiting, pain on
injection, and myoclonus, and has adverse effects on
the endocrine system (7). Etomidate inhibits, in a dosedependent and reversible manner, 11-β-hydroxylase,
which converts 11-deoxycortisol to cortisol. Single
dose etomidate inhibits 11-β-hydroxylase for 5-8 h
postoperation; 11-β-hydroxylase is fully restored
after 20 h (8). At the same time, etomidate leads to
higher rates of nausea and vomiting (around 30%40%) during the postoperative period (7).
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In our study, we aimed to determine the effects
of using etomidate for anesthesia induction on
cortisol, insulin, glucose, and WBC levels, as well as
the incidence of nausea and vomiting in smokers and
nonsmokers.
Materials and methods
After approval was obtained from the Medical Ethics
Committee, 80 patients with ASA I-II status who
were scheduled for noncardiac elective surgery were
included in this study. All patients were between 30
and 60 years old. Patients were divided into 2 groups:
smokers (Group I, n = 40) and nonsmokers (Group
II, n = 40). Patients who smoked 20 cigarettes/day,
had been active smokers for at least 10 years, and were
still smoking 72 h before the operation were included
in Group I. Patients were randomly divided into 2
subgroups and were administered either etomidate
(Group IE, n = 20; Group IIE, n = 20) or propofol
(Group IP, n = 20; Group IIP, n = 20) for anesthesia
induction.

and Group IIP, anesthesia was induced using 2-2.5
mg kg-1 propofol, 0.1 mg kg-1 vecuronium, and 2
μg kg-1 fentanyl. In all of the groups, anesthesia was
maintained using 6% desflurane in a 50% O2-50%
air mixture, and additional doses of vecuronium
and fentanyl were administered if required. At the
end of surgery, in order to remove any residual
muscle relaxation agent, 0.04 mg kg-1 neostigmine
and, if needed, 0.5 mg atropine were administered
intravenously.
Blood samples for cortisol, insulin, glucose,
and white blood cell (WBC) measurements were
collected from patients 10 min before induction and
10 min, 1 h, 2 h, and 8 h after induction. Patients
were monitored for at least 1 h in the postoperative
recovery room and records were kept of their
postoperative nausea vomiting (PONV) scores (0:
no nausea or vomiting; 1: mild nausea, no vomiting,
and no treatment required; 2: moderate nausea,
minimal vomiting, and treatment required; 3: severe
vomiting) and postanesthesia recovery scores (PAS)
(9) 1, 15, 30, 45 and 60 min after surgery.

Patients with neurological, psychiatric, cardiac,
or metabolic disease, diabetes mellitus, endocrine
dysfunction, and/or a known allergy to the
medication were excluded from this study. Patients
were premedicated with 2 mg of midazolam (im)
and 0.5 mg atropine (im) sulfate 45 min before the
operation. Electrocardiography, noninvasive blood
pressure, and peripheral oxygen saturation were
monitored.

The Statistical Package for the Social Sciences 17.0
software was used for statistical evaluation. One-way
ANOVA, the post hoc Tukey HSD test, and Dunnett’s
test were used to compare groups. The paired samples
t-test and Wilcoxon’s test were used for comparisons
within groups. Results with a P value less than 0.05
were considered statistically significant.

Anesthesia was induced using 0.3 mg kg-1
etomidate, 0.1 mg kg-1 vecuronium, and 2 μg kg-1
fentanyl in Group IE and Group IIE. In Group IP

Results
Demographic data did not differ significantly among
the groups (Table).

Table. Demographic data of groups (mean ± SD).
Group IE
(n = 20)

Group IP
(n = 20)

Group IIE
(n = 20)

Group IIP
(n = 20)

34.45 ± 5.34

38.00 ± 8.54

38.15 ± 9.28

34.75 ± 7.26

Operation duration (min)

104.00 ± 11.07

100.00 ± 8.58

102.00 ± 10.18

101.50 ± 11.82

Anesthesia duration (min)

117.00 ± 9.65

115.75 ± 8.47

118.75 ± 8.86

119.50 ± 12.23

Female

13

12

12

12

Male

7

8

8

8

Age (years)

Gender
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Blood insulin levels were significantly higher 8 h
after induction than before induction in Group IE,
Group IP, and Group IIP (P < 0.05). Blood insulin
levels were significantly higher in Group IP compared
to Group IE and Group IIE 8 h postinduction (P <
0.05). No significant difference was found between
groups during any of the other periods (Figure 2).

Cortisol (μg/dL)

In all of the groups, blood glucose levels were
significantly higher at all points after induction
compared to before induction (P < 0.05). Blood
glucose levels were significantly higher in Group
IIE compared to Group IP and Group IIP after the
induction period (P < 0.05). Blood glucose levels
were also significantly higher in Group IIE compared
to Group IP 1 h and 2 h after induction and were
higher in Group IIP compared to Group IE 8 h after
induction (P < 0.05; Figure 3).

21
19
17
15
13
11
9
7
5

Insulin (μIU/mL)

18

†

Group IE
Group IP
Group IIE

14

Group IIP
*

10
6
2
b.i. 10 min a.i. 10 min

1h

2h

8h

Time

Figure 2. The serum insulin values of the groups.
*: P < 0.05 when the 8th h was compared with measurements
taken 10 min before induction (b.i. 10 min) in Group IE,
Group IP, and Group IIE.
†: P < 0.05 when Group IP was compared with Group IE and
Group IIE at 8 h.
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Figure 3. The serum glucose values of the groups.
*: P < 0.05 when the 1st, 2nd, and 8th hours were compared with
measurements taken 10 min before induction (b.i. 10 min) in
Group IE, Group IP, Group IIE, and Group IIP.
†: P < 0.05 when Group IIE was compared with Group IP and
Group IIP before induction.
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‡: P < 0.05 when Group IIE was compared with Group IP at 1 and
2 h.
†
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§: P < 0.05 when Group IIP was compared with Group IIE at 8 h.
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Figure 1. The serum cortisol values of the groups.
*: P < 0.05 when the 1st and 2nd hours were compared with
measurements taken 10 min before induction (b.i. 10 min) in
Group IE and Group IIE.
†: P < 0.05 when Group IE and Group IIE were compared with
Group IIP at 1 h.
‡: P < 0.05 when Group IE and Group IIE were compared with
Group IP and Group IIP at 2 h.
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Glucose (mg/dL)

At 1 h and 2 h postinduction, blood cortisol levels
were significantly lower than before induction in
Group IE and Group IIE (P < 0.05). No statistically
significant difference was found in either Group IP
or IIP. Blood cortisol levels were significantly lower
in Group IE compared to Group IIP, and in Group
IIE compared to Group IIP, 1 h after induction (P
< 0.05). Cortisol levels were significantly lower in
Group IE and Group IIE compared to Group IP and
Group IIP by the 2nd hour (P < 0.05). No statistically
significant difference was demonstrated between
groups before induction, 10 min after induction, or 8
h after induction (Figure 1).

The WBC levels did not significantly differ within
or between groups at any point. PONV scores were
significantly higher in Group IIE compared to Group
IE, Group IP, and Group IIP 1 min, 15 min, and 30
min after surgery (P < 0.05; Figure 4). PAS scores
were significantly higher in Group IE compared to
Group IP 1 min after induction (P < 0.05).
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between smoking and insulin resistance (19). A
previous study also reported that etomidate does
not increase insulin levels (20). In our study, insulin
levels were increased in smokers 8 h after induction,
especially in the propofol-treated group.
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Figure 4. The PONV scores of the groups.
*: P < 0.05 when Group IIE was compared with Group IE at 1
min.
†: P < 0.05 when Group IIE was compared with Group IE, Group
IP, and Group IIP at 15 min.
‡: P < 0.05 when Group IIE compared with Group IE, Group IP,
and Group IIP at 30 min.

Discussion
In our study, we evaluated the effects of etomidate
and smoking on blood cortisol, insulin, glucose, and
WBC levels as well as on PONV. We also investigated
the relationship between etomidate and smoking and
the effect of smoking on PONV and PAS scores.
Etomidate causes a decrease in blood cortisol levels
and an increase in cortisol precursor levels via dosedependent, reversible inhibition of 11-β-hydroxylase,
which converts 11-deoxycortisol to cortisol (7).
Decreased cortisol levels increase or return to normal
values within the 1st hour postoperation or 6-8 h
after anesthesia induction (10-12).

Increased blood glucose levels indicate a stress
response to anesthesia. Studies have demonstrated
that blood glucose levels increase in patients who
are administered propofol for anesthesia induction
and maintenance (21,22). Moore et al. (23) showed
that patients who received etomidate anesthesia had
higher glucose levels throughout their procedure.
Studies of WBC levels during the postoperative
period have indicated both increased (24) and
unaffected (25,26) WBC levels depending on the
anesthesia and surgical technique used (27). As in
our study, Kulacoglu et al. (24) demonstrated that
general and spinal anesthesia did not affect WBC
levels although local anesthesia increased WBC
levels during the first 24 h postoperation. Other
studies have also focused on the first postoperative
day to demonstrate the increase in WBCs, unlike the
present study (24,26,27). Brohee et al. (28) showed
that cortisol and epinephrine increased the WBC
level in a healthy volunteer. Two differences between
these previous studies and our study may explain why
we did not observe any significant changes in WBC
levels. First, the sampling time interval was different
in the other studies and, second, the cortisol level was
not high in all groups.

Although propofol has been demonstrated to
inhibit adrenal steroidogenesis in vitro (13), it has
been shown to increase cortisol levels in in vivo
studies. As a result, propofol was thought not to affect
adrenocortical inhibition (14). Though previous
studies have demonstrated that smoking increases
plasma and salivary gland cortisol levels (6,15), we
did not find a significant difference between the
cortisol levels of smokers and nonsmokers at any
time in our study.

Smoking has been shown to have a protective
effect against postoperative nausea and vomiting.
Although the underlying mechanism is still
unknown, it is a fact that nicotine is an antiemetic
(29). The type of anesthesia used and the method of
administration influence the frequency of PONV
most (30). Many antiemetic medications are used for
preventing PONV (31). Propofol regulates nausea
and vomiting by interacting with dopaminergic
D2 receptors. When propofol is used for general
anesthesia, it causes less postoperative nausea and
vomiting relative to inhalation anesthetics and it
decreases the use of antiemetic drugs (32).

Previous studies have demonstrated an increased
risk for diabetes among smokers (16) and a link
between insulin resistance and smoking (17,18).
However, another study found no correlation

In our study, the number of patients complaining
of nausea and vomiting was significantly higher
among nonsmoking patients who were administered
etomidate. Thus, we concluded that smoking and
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anesthesia induction with propofol decrease the
frequency of PONV. We observed that smoking
counteracted the effects of etomidate on PONV. In
our study, the frequency of PONV was significantly
lower for smoking patients, who had high cortisol
levels, compared to nonsmoking patients with low
blood cortisol levels. Therefore, we concluded that the
increased blood cortisol levels may have decreased the
frequency of PONV. Smokers who received etomidate
for anesthesia induction also had significantly higher
PAS values during the recovery period compared to
the patients who received propofol. We determined
that this finding was related to the use of desflurane
for anesthesia maintenance in all groups.

In conclusion, in our study, we determined
that the surgical stress response is lower when
etomidate anesthesia is administered rather than
propofol anesthesia. The stress response is higher in
smokers anesthetized with etomidate. However, we
observed that anesthesia induction with propofol
caused significantly lower rates of PONV compared
to anesthesia induction with etomidate. Smokers
anesthetized with etomidate had rates of PONV
comparable to those of nonsmokers anesthetized with
propofol. Additional studies are required to examine
endocrine system changes, PONV, and the comfort
of smoking patients during and following anesthesia.
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